Imunoterapi Dokter Terbaik - TOP-55 dokter

• Mengkhususkan diri dalam imunoterapi kanker dan terapi terarah.
• Terlatih dalam imunoonkologi di Mount Vernon Cancer Center, London, Inggris.
• Tersertifikasi oleh European Society of Medical Oncology (ESMO).
• Anggota ESMO dan European School of Oncology.
• Berpraktik di Amerika Serikat dan Turki.

• Spesialis dalam imunoterapi kanker menggunakan terapi target.
• Telah menjalani pelatihan di Turki dan di Komando NATO KFOR.
• Anggota Asosiasi Onkologi Medis Turki.
• Lebih dari 40 publikasi dalam penelitian kanker, dengan fokus pada imunoterapi.
• Profesor di Fakultas Kedokteran Universitas Okan Istanbul.

Dr. Sinan Karaaslan — Dokter Onkologi Medis di Anadolu Medical Center (sejak 2014). Ia menangani kanker payudara, kolorektal, dan genitourinari; dalam onkologi medis sejak 2003. Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.

Mengapa pasien memilih dan mempercayai Dr. Karaaslan:

• Menangani kasus kanker payudara, kolorektal, dan genitourinari yang kompleks — menerapkan terapi sistemik modern yang disesuaikan dengan tipe dan stadium tumor.
• Anggota dari Asosiasi Medis Turki, Masyarakat Onkologi Medis Turki, dan Masyarakat Kanker Paru-Paru Turki.
• Penulis dari banyak artikel yang telah ditinjau sejawat dan materi edukasi pasien tentang kemoterapi dan imunoterapi.
• Bekerja di pusat dengan status ESMO Designated Centre dan akreditasi JCI, dalam kolaborasi strategis dengan Johns Hopkins Medicine International — salah satu institusi medis terkemuka di AS. Bagi pasien, ini berarti perawatan yang sesuai dengan protokol AS dan penggunaan peralatan canggih.

Dia telah bekerja sebagai dokter spesialis penyakit dalam dan spesialis onkologi medis di Pusat Medis Anadolu sejak tahun 2021.
 

Dr. Serkan Keskin adalah seorang ahli onkologi yang sangat berpengalaman, dengan spesialisasi dalam kemoterapi. Ia memiliki banyak prestasi di bidangnya, termasuk meraih peringkat pertama dalam Ujian Kecakapan Onkologi Medis di Turki pada tahun 2012. Ia adalah anggota aktif dari berbagai masyarakat onkologi bergengsi, dan memiliki profil akademis yang kuat dengan 42 artikel yang diterbitkan dalam jurnal internasional.

• Menggunakan inhibitor pos pemeriksaan dan terapi CAR T-sel untuk imunoterapi.
• Dilatih di Turki dan Amerika Serikat, termasuk di MD Anderson Cancer Center.
• Anggota American Society of Clinical Oncology.
• Spesialis dalam imunoterapi untuk berbagai jenis kanker termasuk paru-paru dan payudara.
• Menyelesaikan program fellowship di Institut Kanker Universitas Hacettepe.

• Menggunakan inhibitor pos pemeriksaan dan antibodi monoklonal dalam pengobatan imunoterapi.
• Memiliki pelatihan internasional dan pengalaman praktik di Turki.
• Merupakan anggota Asosiasi Onkologi Medis Eropa dan Asosiasi Onkologi Klinis Amerika.
• Memiliki lebih dari 20 tahun pengalaman dalam pengobatan kanker dan imunoterapi.
• Telah menulis lebih dari 40 artikel tentang kemajuan dalam pengobatan kanker.

• Menggunakan inhibitor titik pemeriksaan dan antibodi monoklonal untuk pengobatan imunoterapi.
• Telah dilatih dan berpraktik secara internasional, termasuk di Turki.
• Merupakan anggota dari European Society for Medical Oncology.
• Telah dianugerahi Penghargaan Penelitian Onkologi oleh Asosiasi Onkologi Medis Turki.
• Telah menulis lebih dari 20 makalah tentang onkologi medis.

Salah satu spesialis kanker terbaik di Eropa, pendidik, dan peneliti kanker, Presiden Central European Cooperative Oncology Group (CECOG).
Telah menerbitkan lebih dari 600 makalah ilmiah tentang pengobatan kanker.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Manuela Seifert adalah spesialis terkemuka asal Jerman dalam bidang penyakit payudara.

Spesialisasi

Dr. Manuela Seifert adalah spesialis dalam diagnostik, terapi, dan perawatan lanjutan penyakit payudara serta sonografi.

Dr. Seifert menerapkan operasi yang mempertahankan payudara sebagai metode pengobatan utama.

Pengalaman Kerja

• Sejak 2016 – Kepala Klinik Payudara di Pusat Medis di Solingen
• 2012-2016 – Spesialis payudara & senologi di Helios Universitätsklinikum Wuppertal
• 2001-2012 – Dokter spesialis kandungan dan kebidanan senior di Departemen Ginekologi & Kebidanan di Klinikverbund St. Antonius und St. Josef GmbH.

Pendidikan

• Fakultas Kedokteran Universitas Heinrich-Heine – Gelar dalam kedokteran umum
• Klinikverbund St. Antonius und St. Josef GmbH – Spesialisasi dalam ginekologi dan kebidanan.

• Spesialis dalam transfer sel adopsi dan inhibitor pos pemeriksaan untuk imunoterapi.
• Telah dilatih di Jerman, dengan kolaborasi internasional yang luas.
• Diakui sebagai ahli onkologi terkemuka di Jerman oleh peringkat Focus.
• Onkolog bersertifikat, anggota Perhimpunan Kanker Jerman.

Prof. Ralf Buhl is world famous neurosurgeon with over 20 years of experience. Doctor Buhl heads the Neurosurgery Department at Solingen Klinikum. His reputation reaches China and the US where he provides neurosurgical lectures.

Specialty

Dr. Buhl specializes in non-invasive methods treatment of disc herniation, brain and spinal cord tumors. The doctor provides treatment of peripheral nervous system disorders and performs computer-assisted navigation microsurgeries.

Dr. Ralf Buhl has provided over 4,000 successful neurosurgeries. Among his patients are famous politicians, businessmen, musicians, actors. In 2015, a Hollywood star George Clooney had severe back pain and was treated by Professor Buhl.

Scientific activity

Dr. Buhl conducts scientific work and researches in intracranial cavernomas treatment, surgical treatment for brain metastases and other neurosurgery areas.

Рrofessor Buhl has cofound the Fund devoted to the study of brain tumors.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.

His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.

Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.

Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.

Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.

Professor of Oncology and Hematology